by Dr Lorraine Marsh | Nov 9, 2021 | Pharmacovigilance, Regulatory Affairs
EU processing of PSURs/ PBRERs Today we are focusing on the processing of Periodic Safety Update Reports (PSURs)/ Periodic Benefit Risk Evaluation Reports (PBRERs) for medicinal products in the EU. This blog follows on from my previous blogs on this topic. Don’t...
by Dr Lorraine Marsh | Oct 21, 2021 | Pharmacovigilance, Regulatory Affairs
How to prepare your PSURs/ PBRERs Today we are continuing our series on PSURs and PBRERs by focusing on how to prepare your Periodic Safety Update Reports (PSURs)/ Periodic Benefit Risk Evaluation Reports (PBRERs) for medicinal products. Don’t miss the important...
by Dr Lorraine Marsh | Oct 19, 2021 | Pharmacovigilance, Regulatory Affairs
An introduction to PSURs and PBRERs Today I am introducing Periodic Safety Update Reports (PSURs)/ Periodic Benefit Risk Evaluation Reports (PBRERs) for medicinal products. Don’t miss the important tip for today at the end of this blog… What...
by Guest Blogger | Sep 13, 2021 | Guest Blog, Medical, Pharmacovigilance, Quality, Regulatory Affairs
We are delighted to introduce Michelle Bridgman who brings along with her 10 years of experience working as a Pharmaceutical Brand Marketer with Prescription Medicines, OTCs and Medical Devices. Michelle understands well the benefits and importance of cross-functional...
